Thermo Fisher Scientific to buy Olink in $3.1 billion deal (updated)

Olink Holding AB (publ)

17/10/2023 13:49

(Adds details throughout)
       Oct 17 (Reuters) - Thermo Fisher Scientific  TMO.N  said
on Tuesday it would acquire Olink Holding AB  OLK.O  in a deal
valued at $3.1 billion as the U.S. medical equipment maker seeks
to boost its life sciences portfolio that helps in drug
discovery.
    Thermo Fisher said it would pay the Sweden-based provider of
protein analysis products $26.00 per common share in cash.  
    The deal, expected to be completed by mid-2024, represents a
premium of about 74% to Olink's closing price on Monday.
     

 (Reporting by Mariam Sunny in Bengaluru; Editing by Krishna
Chandra Eluri and Shilpi Majumdar)
 ((Mariam.ESunny@thomsonreuters.com;))